"Precision medicine" is allowing us to analyse a person's genetic makeup and target treatments based on their specific needs.
Academic rigour, journalistic flair
Articles on Precision medicine series
Displaying all articles
It's exciting to think we're on the brink of a genomic revolution in health care. But just because new technology becomes available, it doesn't mean it should automatically be publicly funded.
CRISPR harnesses the natural defence mechanisms of some bacteria to cut human DNA strands. Then the DNA strand either heals itself or we inject new DNA to mend the gap. This is gene editing.
In 2030, there is a boom in precision medicine, where diseases – from cancer to dementia – are defined and targeted more specifically with a focus on their molecular makeup.
Job Board
Where experts find jobs
-
Research Fellow, Grade 1
-
Library Adviser (Specialist)
-
Associate Professor in Marketing
-
Lecturer Or Senior Lecturer Taxation/Accounting
-
Senior Opportunity in Governance, Risk and Compliance
Top contributors
-
Professor of Health Economics and Director, Centre for Health Economics Research and Evaluation, University of Technology Sydney
-
Stephen Duckett is a Friend of The Conversation.
Director, Health Program, Grattan Institute
-
Deputy Vice-Chancellor Academic and Professor of Molecular Biology, UNSW
-
Professor of Health Economics, University of Technology Sydney
-
Executive Director, Garvan Institute of Medical Research, Garvan Institute
-
Professor, Central Clinical School, Monash University
